• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    New Wearable Sends Vital Signs 15 Miles Without Cell Service

    Keystone Medical Technologies Opens Manufacturing Facility in Chattanooga, TN

    Withings Unveils ScanWatch Nova

    DiagnaMed Debuts New Healthcare Provider Network Program

    Dinsmore Becomes HP Digital Manufacturing Partner
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    A Peek Into the 2028 MPO Summit

    Retail Healthcare Disruptors and Medical Devices

    Six Developments Your Talent Strategy Should Prepare for in 2024

    The Power and Paradox of Never

    Navigating the Q-Sub Program: How Experienced Lab Partners Can Help Streamline Regulatory Submission
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    Arthur G Russell Company, The

    LEMO USA Inc.

    Qosina Corp.

    Johari Digital Healthcare Ltd.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Telemedicine for Neurology: 5 Benefits of Remote Management

    Machining 101: A Review of Machining Components with a Five-Axis System

    MedTech 2024: Top 5 Trends Shaping a Dynamic Industry

    Early Warning: A Q&A with Abbott's CMO of Heart Failure

    2023 in Review: Medtech's Mega-M&A Is MIA
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    Arthur G Russell Company, The

    LEMO USA Inc.

    Qosina Corp.

    Johari Digital Healthcare Ltd.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Abbott Begins Trial for Patients with Simultaneous AFib and Heart Failure

    Will use cardiac ablation and sensors to monitor pulmonary artery pressure and abnormal heartbeats.

    Abbott Begins Trial for Patients with Simultaneous AFib and Heart Failure
    Sam Brusco, Associate Editor05.06.21
    Abbott began a trial focused on improving treatment for patients simultaneously battling atrial fibrillation (AFib) and heart failure. The first-of-its-kind trial aims to provide new insights into more effective treatment for patients with AFib and heart failure, a complex combination that has presented significant challenges.
     
    The new TAP-CHF trial (Evaluating the Treatment of Atrial Fibrillation in Preserved Cardiac Function Heart Failure) aims to discover better management options for patients with AFib and heart failure with preserved ejection fraction (HFpEF)—a type of heart failure where the heart cannot relax and fill with blood effectively prior to pumping. Combined, these conditions can be very difficult to control because they increase pressure on the pulmonary arteries. The two conditions increase the risk of stroke, hospitalization, or even death.
     
    "Cardiovascular patients often have more than one heart condition. We believe that we can best help those patients live longer and better lives by providing their doctors improved therapy approaches that address the entirety of their heart disease," Philip Adamson, M.D., chief medical officer for Abbott's heart failure business told the press. "Trials that look at complex heart conditions together promise to offer new insights and will make a tremendous difference in the outcomes of our patients now and into the future."
     
    The TAP-CHF trial will manage patients in two phases to better help physicians understand the impact of monitoring pulmonary pressure fluctuations.
     
    • In the first phase, physicians will deploy either cardiac ablation or medication to control erratic heart rhythms in AFib patients with a history of heart failure.
    • Following treatment for AFib, all patients will receive the Abbott Confirm Rx insertable cardiac monitor to help physicians monitor for recurrent abnormal heart rhythms.
    • In the second phase, physicians will randomize patients to receive typical clinical management for heart failure based on symptom changes or to heart failure management guided by data from Abbott's CardioMEMS HF System, a pulmonary pressure sensor that can provide early warning of worsening heart failure.
     
    Abbott expects the TAP-CHF trial to enroll up to 100 patients at 10 trial sites in the U.S. At the end of the trial, outcomes of patients who had their heart failure management guided by data from the CardioMEMS HF System will be compared to those who received standard of care (medicine) for their heart failure to determine which patient group had better outcomes based on recurrence of AFib, hospitalization or death. The trial will also provide insights into the effect of catheter ablation in patients with HFpEF.
     
    "Heart failure in patients with preserved ejection fraction is a major unsolved public health challenge worldwide, with few effective avenues of treatment. This is compounded by the fact that AFib affects nearly half of these patients, increasing the risk of mortality and increased hospitalization," said Sanjeev Saksena, M.D., principal investigator of the TAP-CHF trial, clinical professor of medicine at the Rutgers' Robert Wood Johnson Medical School and medical director at the Electrophysiology Research Foundation. "In partnership with innovation leaders such as Abbott, we've made significant progress in how we treat patients battling AFib, and we've also made progress in how we manage heart failure. But to continue to treat people more effectively who are facing both conditions, we need innovative treatment strategies, fresh insights and confirmation of new therapeutic approaches."
     
    The TAP-CHF trial is an investigator-initiated phase 4, sequential, randomized, open label, and multicenter prospective comparative study to address the major health challenge presented by HFpEF and AFib. The trial is administered by the Electrophysiology Research Foundation and involves worldwide leaders in deploying innovative therapies for both conditions.
    Related Searches
    • Patient Monitoring
    • Cardiovascular
    Related Knowledge Center
    • Patient Monitoring
    • Cardiovascular
    Suggested For You
    Junkosha USA Inc. Junkosha USA Inc.
    Heraeus Medevio Heraeus Medevio
    sfm medical devices GmbH sfm medical devices GmbH
    JK Medirise-Disposable Medical Device Company JK Medirise-Disposable Medical Device Company
    Northeast Biomedical Inc. Northeast Biomedical Inc.
    BMP Medical - Delivering Custom Plastics Manufactured Solutions BMP Medical - Delivering Custom Plastics Manufactured Solutions
    High Tech Turning Co. Inc. High Tech Turning Co. Inc.
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Accu-Tube Appoints Matthew Haddle as CEO Accu-Tube Appoints Matthew Haddle as CEO
    First CellFX Procedure Performed in Canada First CellFX Procedure Performed in Canada
    Turner Imaging Systems Announces International Expansion Turner Imaging Systems Announces International Expansion
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021 MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021
    Boston Scientific Agrees to Acquire Devoro Medical Boston Scientific Agrees to Acquire Devoro Medical

    Related Buyers Guide Companies

    • Junkosha USA Inc.

      Junkosha USA Inc.

      ...
      Andy Parker, Director 11.29.23

    • Heraeus Medevio

      Heraeus Medevio

      Heraeus is a globally active precious metals and technology Group with firm roots in Germany, headquartered in Hanau near Frankfurt.
      Sara Kruper, Global Marketing Manager 10.17.23

    • sfm medical devices GmbH

      ...
      Albert Busch, Head of Marketing 10.17.23


    • JK Medirise-Disposable Medical Device Company

      ...
      Ketan Munjani, Marketing Manager 09.28.23

    • Northeast Biomedical Inc.

      ...
      Timothy Looney, Northeast Biomedical, Inc. 11.18.22

    Loading, Please Wait..

    Breaking News
    • New Wearable Sends Vital Signs 15 Miles Without Cell Service
    • Keystone Medical Technologies Opens Manufacturing Facility in Chattanooga, TN
    • Withings Unveils ScanWatch Nova
    • DiagnaMed Debuts New Healthcare Provider Network Program
    • Dinsmore Becomes HP Digital Manufacturing Partner
    View Breaking News >
    CURRENT ISSUE

    November 2023

    • MPO's 2023 Medical Device Industry Year in Review
    • The Beat Goes On in the Cardiovascular Device Market
    • Medical Manufacturers Gain Support from 3D Printing
    • The Intelligent Tools Medical Device Manufacturers Already Own
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress
    NutraShure Introduces SA3X as Exclusive US Supplier
    NPA Lawsuit Claims New York Age Restriction on Supplements is Unconstitutional
    Coatings World

    Latest Breaking News From Coatings World

    Albert Extends Coverage of Transformational Regulatory Automation Capabilities to China and Taiwan
    BCF Urges Government to Recognize Importance of Coatings Industry
    AkzoNobel Graduates First Engineers from Training Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    New Wearable Sends Vital Signs 15 Miles Without Cell Service
    Keystone Medical Technologies Opens Manufacturing Facility in Chattanooga, TN
    Withings Unveils ScanWatch Nova
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Abzena, ProteoNic Partner to Offer Enhanced CHO Cell Line Platform
    AQEMIA Inks $140M Small Molecule Deal with Sanofi
    Hoth Therapeutics, WuXi STA Complete Manufacturing of HT-KIT
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Honest Company Expands Partnership with Tinuiti
    DedCool Introduces New Sephora-Exclusive Fragrance
    MAC Cosmetics Brings Back Fizzy Feels Lip Balm
    Happi

    Latest Breaking News From Happi

    Naples Soap Company Reports Record-High Sales During Thanksgiving Weekend 2023
    Glo30 Welcomes Artemis Benedetti as New Director of Franchise Operations
    Trace Minerals Taps Charles Walkley as Chief Operating Officer
    Ink World

    Latest Breaking News From Ink World

    Avient Attains ACC Responsible Care 14001 Global Certification
    BCF Urges Government to Recognize Importance of Ink and Coatings
    CCL Industries Names Claude Tessier to Board of Directors
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    All4Labels Group acquires Uniflexo
    Rosas Maschinenbau introduces new RFID label converting line
    Lecta unveils new functional Metalvac papers
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    INDA Seeking Abstracts for World of Wipes International Conference
    Monadnock Introduces New Generation of Veils
    G-P Invests in Oregon Facility
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Sonex Health Raises $40 Million in Series B Financing
    Precision Medical Technologies Rebrands
    Nalu SCS System Shows 75% Pain Reduction in U.S. Study
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Four Scientists Receive Battelle Distinguished Inventor Recognition
    Applied Materials and CEA-Leti Unveil Joint Lab for Specialty Chip Markets
    Sandvik Manufacturing Partners with RISE

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login